Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00692-21Source: DataRank Database

Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae is a research paper published in Antimicrobial Agents and Chemotherapy (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (43)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Karol Sokolowski ORCID,Amisha P. Rana ORCID,Nidhi Singh ORCID,Jiping Wang ORCID,Ke Chen ORCID

Live enrichment

PubMed:34152820

Chicago Biomedical Consortium

Grant: C89

Australian National Health and Medical Research Council

Grant: Principal Research Fellow

HHS | National Institutes of Health

Grant: KL2TR002002

HHS | National Institutes of Health

Grant: R01AI136803

National Institutes of Health

Grant: 5R01AI136803-03

Combating resistant superbugs by understanding the molecular determinants of target site penetration and binding

National Institutes of Health

Grant: 3KL2TR002002-02S1

Institutional Career Development

NIAID NIH HHS

Grant: U19 AI135964

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8370209

publisherhttps://journals.asm.org/doi/pdf/10.1128/AAC.00692-21

https://doi.org/10.1128/aac.00692-21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370209

https://pubmed.ncbi.nlm.nih.gov/34152820

Fields of Study

0301 basic medicine03 medical and health sciencesAminoglycosidesAnimalsAnti-Bacterial AgentsAzabicyclo CompoundsCeftazidimeDrug CombinationsGenotypeKlebsiella InfectionsKlebsiella pneumoniaeMiceMicrobial Sensitivity Testsbeta-Lactamases

MeSH Terms

AminoglycosidesAnimalsAnti-Bacterial AgentsAzabicyclo CompoundsCeftazidimeDrug CombinationsGenotypeKlebsiella InfectionsKlebsiella pneumoniaeMiceMicrobial Sensitivity Testsbeta-Lactamases

Keywords

Aminoglycoside-modifying enzymesGenotypeMicrobial Sensitivity TestsCeftazidimebeta-LactamasesAnti-Bacterial AgentsKlebsiella InfectionsAntimicrobial combinationsCarbapenemaseKPCDrug CombinationsKlebsiella pneumoniaeMiceAminoglycosidesKlebsiellaAnimalsAzabicyclo Compounds

Sustainable Development Goals

SDG 3: 3. Good health